coin-img-XRPXRP+3.01%coin-img-USDCUSDC+0.00%coin-img-BTCBTC+1.59%coin-img-ETHETH+1.06%coin-img-SOLSOL+0.05%coin-img-FLYAIFLYAI+0.00%coin-img-AAVEAAVE+5.43%coin-img-DOGEDOGE+1.72%coin-img-XRPXRP+3.01%coin-img-USDCUSDC+0.00%coin-img-BTCBTC+1.59%coin-img-ETHETH+1.06%coin-img-SOLSOL+0.05%coin-img-FLYAIFLYAI+0.00%coin-img-AAVEAAVE+5.43%coin-img-DOGEDOGE+1.72%coin-img-XRPXRP+3.01%coin-img-USDCUSDC+0.00%coin-img-BTCBTC+1.59%coin-img-ETHETH+1.06%coin-img-SOLSOL+0.05%coin-img-FLYAIFLYAI+0.00%coin-img-AAVEAAVE+5.43%coin-img-DOGEDOGE+1.72%coin-img-XRPXRP+3.01%coin-img-USDCUSDC+0.00%coin-img-BTCBTC+1.59%coin-img-ETHETH+1.06%coin-img-SOLSOL+0.05%coin-img-FLYAIFLYAI+0.00%coin-img-AAVEAAVE+5.43%coin-img-DOGEDOGE+1.72%
user-avatar
scanx.trade

Fabtech Cleanrooms clears ₹15,00,00,134 preferential warrant issue to promoters

AI Market Summary
Fabtech Cleanrooms approved a ₹15 crore preferential issue of convertible warrants to promoters, priced at ₹394, with conversion within 18 months pending shareholder and regulatory approvals. The action is a routine capital-raising tool that may marginally strengthen liquidity but also implies potential dilution upon conversion. Separately, management highlighted a sizeable order book and pipeline in pharma and renewable energy, supporting near-term business visibility.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+1.85%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Fabtech Cleanrooms has approved a preferential issue of 3,80,711 convertible warrants to promoters and promoter group members at ₹394 per warrant, seeking to raise ₹15,00,00,134 on July 20, 2026. The warrants are convertible into equity shares of face value ₹10 each within 18 months of allotment, subject to shareholder and regulatory approvals. The company also reported a consolidated order book of ₹362.41 crore as of June 30, 2026, with orders under active consideration of ₹514.78 crore, led by Pharma and Renewable Energy.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.